published October 15, 2025
Welcome to the October 2025 Lymphoma Australia Newsletter Inside this edition we cover the following topics:
published September 22, 2025
September is Lymphoma Awareness Month! Channel 7 news and our new Lymphoma Australia ambassadors AFL great
published September 1, 2025
Welcome to the Latest Edition of the Lymphoma Australia Newsletter September is World Lymph
published August 26, 2025
In July 2025, the Pharmaceutical Benefits Advisory Committee (PBAC) recommended three new medicines for treati
published July 14, 2025
We’re going Dry for July, Upcoming support groups, fertility, What’s new in mantle cell lymphoma and more…
published July 14, 2025
Updates for 2026 Nurse Conference, EOI Melbourne Lymphoma Care Nurse, Nurse Dinners, Spotlight on MCL and more
published July 13, 2025
In this month’s newsletter you will find: 🔹Spotlight on Hodgkin Lymphoma – Understanding subtypes, di
published July 13, 2025
In this newsletter you will find: 📖Conference Update 👩‍⚕️Who is Sarah? 💚Recently published
published July 13, 2025
  In this month’s newsletter you will find: What have we been up to? Legs out for Lymphoma (
published July 13, 2025
In this newsletter we will be sharing the following updates: Christmas message Our year in revie
published June 3, 2025
Great news for patients in QLD with another hospital accredited to provide CAR T-cell therapy for eligible pat
published May 8, 2025
May 2025 Inside this edition, we will be covering treatment updates, benefit Upcoming Support Groups Exe

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.